ENTITY

Braveheart Bio (BRVE US)

9
Analysis
Health Care • United States
Braveheart Bio, Inc. is a clinical-stage biotechnology company. The Company focuses on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and related conditions by targeting overactive proteins within the heart. Braveheart Bio serves customers in the United States.
more
Presentation Icon
No presentations found
We’ll display presentations we find for Braveheart Bio here
x